Search Results 551-560 of 16678 for CLL
-
Patients on immunosuppressive therapy, for example history of organ or bone marrow transplant or chronic lymphocytic leukemia (CLL). CD4 count < 200 cells ...
-
Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma. Int J Dermatol. 2017 Nov; 56 (11): ...
-
This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...
-
Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal plasma cells[...] ...
-
Sikander Ailawadhi, M.D.. Oncologist. Jacksonville, FL. Areas of focus: Multiple myeloma, Leukemia, Chronic lymphocytic leukemia, Waldenstrom macroglobulinemia, ...
-
The purpose of this study is to identify factors important to decision-making for older adults with indolent lymphomas and to identify minimum clinically ...
-
David Etzioni, a Mayo Clinic colorectal surgeon, reminds people that early diagnosis and treatment are crucial to ensure better outcomes, and that it all starts ...
-
The purpose of this study is evaluation of tumoral markers at the time of transplant to assess recurrence risk, and assessment of tumor sensitivity to a panel ...
-
... chronic lymphocytic leukemia (CLL) and B-cell acute lymphoblastic leukemia (B-cell ALL) using primary tumor and/or patient derived xenograft models, and to ...
-
Known immunosuppressive disease, for example history of bone marrow transplant or chronic lymphocytic leukemia (CLL). Patients positive for human ...